Erythropoietin a safe bet in haemorrhagic shock?

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 5, 2008, Pages 585-586

  Gjertsen, B T ^a   Mc Cormack, E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; HEMOGLOBIN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; APOPTOSIS; BLEEDING; BLOOD; BONE MARROW CELL; CRITICALLY ILL PATIENT; EDITORIAL; ERYTHROCYTE; ERYTHROPOIESIS; HEMODILUTION; HEMORRHAGIC SHOCK; HUMAN; HYPOXIA; INFLAMMATION; INTENSIVE CARE; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION;

ANIMALS; ERYTHROPOIETIN; HUMANS; MICE; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42249107817     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2008.01651.x     Document Type: Editorial

References (10)

1. Robinson Y, Matenov A, Tschöke SK et al. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo. Acta Anaesthes Scand 2008 52 : 605 13.
2. Diwan A, Koesters AG, Odley AM et al. Unrestrained erythroblast development in Nix-/- mice reveals a mechanism for apoptotic modulation of erythropoiesis. Proc Natl Acad Sci USA 2007 104 : 6794 9.
3. Robinson Y, Hostmann A, Matenov A et al. Erythropoiesis in multiply injured patients. J Trauma 2006 61 : 1285 91.
4. Corwin HL. Erythropoietin use in critically ill patients: forest and trees. Can Med Assoc J 2007 177 : 747 9.
5. Rizzo JD, Somerfield MR, Hagerty KL et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood 2008 111 : 25 41.
6. Del Vecchio L, Pozzoni P, Andrulli S et al. Inflammation and resistance to treatment with recombinant human erythropoietin. J Ren Nutr 2005 15 : 137 41.
7. Zarychanski R, Turgeon AF, McIntyre L et al. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. Can Med Assoc J 177 : 725 34.
8. Ehrenreich H, Hasselblatt M, Dembowski C et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002 8 : 495 505.
9. Springborg JB, Møller C, Gideon P et al. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial. Acta Neurochir (Wienberg) 2007 149 : 1089 101.
10. Parsa CJ, Matsumoto A, Kim J et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest 2003 112 : 999 1007.